ABSTRACT
Background/Purpose Sarcopenia is a prognostic factor in patients with head and neck cancer (HNC). Sarcopenia can be determined using the skeletal muscle index (SMI) calculated from cervical neck SM segmentations. However, SM segmentation requires manual input, which is time-consuming and variable. Therefore, we developed a fully-automated approach to segment cervical vertebra SM.
Materials/Methods 390 HNC patients with corresponding contrast-enhanced computed tomography (CT) scans were utilized (300-training, 90-testing). Ground-truth single-slice SM segmentations at the C3 vertebra were manually generated. A multi-stage deep learning pipeline was developed, where a 3D ResUNet auto-segmented the C3 section (33 mm window), the middle slice of the section was auto-selected, and a 2D ResUNet auto-segmented the auto-selected slice. Both the 3D and 2D approaches trained five sub-models (5-fold cross-validation) and combined sub-model predictions on the test set using majority vote ensembling. Model performance was primarily determined using the Dice similarity coefficient (DSC). Predicted SMI was calculated using the auto-segmentation cross-sectional area. Finally, using established SMI cutoffs, we performed a Kaplan-Meier analysis to determine associations with overall survival.
Results Mean test set DSC of the 3D and 2D models were 0.96 and 0.95, respectively. Predicted SMI had high correlation to the ground-truth SMI in males and females (r>0.96). Predicted SMI stratified patients for overall survival in males (log-rank p = 0.01) but not females (log-rank p = 0.07), consistent with ground-truth SMI.
Conclusion We developed a high-performance, multi-stage, fully-automated approach to segment cervical vertebra SM. Our study is an essential step towards fully-automated sarcopenia-related decision-making.
Competing Interest Statement
C.D.F. has received direct industry grant support, speaking honoraria, and travel funding from Elekta AB. The other authors have no conflicts of interest to disclose.
Funding Statement
This work was supported by the National Institutes of Health (NIH)/National Cancer Institute (NCI) through a Cancer Center Support Grant (CCSG; P30CA016672-44). M.A.N. is supported by an NIH grant (R01DE028290-01). K.A.W. is supported by a training fellowship from The University of Texas Health Science Center at Houston Center for Clinical and Translational Sciences TL1 Program (TL1TR003169), the American Legion Auxiliary Fellowship in Cancer Research, and an NIH/National Institute for Dental and Craniofacial Research (NIDCR) F31 fellowship (1 F31DE031502-01). A.J.G received funding from the National Cancer Institute (K08 245188, R01 CA264133) and the American Association for Cancer Research/Mark Foundation Science of the Patient Award (20-60-51-MARK). B.O. received funding from the Radiologic Society of North America Research Medical Student Grant (RMS2026). V.S. received funding from The University of Texas, Graduate School of Biomedical Sciences Graduate research assistantship. C.D.F. received funding from the NIH/NIDCR (1R01DE025248-01/R56DE025248); an NIH/NIDCR Academic-Industrial Partnership Award (R01DE028290); the National Science Foundation (NSF), Division of Mathematical Sciences, Joint NIH/NSF Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD) Grant (NSF 1557679); the NIH Big Data to Knowledge (BD2K) Program of the NCI Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award (1R01CA214825); the NCI Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program (1R01CA218148); an NIH/NCI Pilot Research Program Award from the UT MD Anderson CCSG Radiation Oncology and Cancer Imaging Program (P30CA016672); an NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award (P50CA097007); and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) Research Education Program (R25EB025787).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study involves only openly available human data, which can be obtained from https://wiki.cancerimagingarchive.net/display/Public/HNSCC.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding Statement: This work was supported by the National Institutes of Health (NIH)/National Cancer Institute (NCI) through a Cancer Center Support Grant (CCSG; P30CA016672-44). M.A.N. is supported by an NIH grant (R01DE028290-01). K.A.W. is supported by a training fellowship from The University of Texas Health Science Center at Houston Center for Clinical and Translational Sciences TL1 Program (TL1TR003169), the American Legion Auxiliary Fellowship in Cancer Research, and an NIH/National Institute for Dental and Craniofacial Research (NIDCR) F31 fellowship (1 F31DE031502-01). A.J.G received funding from the National Cancer Institute (K08 245188, R01 CA264133) and the American Association for Cancer Research/Mark Foundation “Science of the Patient” Award (20-60-51-MARK). B.O. received funding from the Radiologic Society of North America Research Medical Student Grant (RMS2026). V.S. received funding from The University of Texas, Graduate School of Biomedical Sciences Graduate research assistantship. C.D.F. received funding from the NIH/NIDCR (1R01DE025248-01/R56DE025248); an NIH/NIDCR Academic-Industrial Partnership Award (R01DE028290); the National Science Foundation (NSF), Division of Mathematical Sciences, Joint NIH/NSF Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD) Grant (NSF 1557679); the NIH Big Data to Knowledge (BD2K) Program of the NCI Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award (1R01CA214825); the NCI Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program (1R01CA218148); an NIH/NCI Pilot Research Program Award from the UT MD Anderson CCSG Radiation Oncology and Cancer Imaging Program (P30CA016672); an NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award (P50CA097007); and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) Research Education Program (R25EB025787).
Conflict of Interest: C.D.F. has received direct industry grant support, speaking honoraria, and travel funding from Elekta AB. The other authors have no conflicts of interest to disclose.
medRxiv author list used for indexing purposes was incomplete.
Data Availability
All raw imaging data are available online at: https://wiki.cancerimagingarchive.net/display/Public/HNSCC. Segmentation data are avaliable upon reasonable request to the authors.
Abbreviations
- CT
- (computed tomography)
- DSC
- (Dice similarity coefficient)
- HNC
- (head and neck cancer)
- ROI
- (region of interest)
- SM
- (skeletal muscle)
- SMI
- (skeletal muscle index)